Cargando…

Evaluation of extended and continuous use oral contraceptives

Oral contraceptives are classically given in a cyclic manner with 21 days of active pills followed by 7 days of placebo. In the past 4 years, new oral contraceptives have been introduced which either shorten the placebo time, lengthen the active pills (extended cycle), or provide active pills every...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Kristen Page, Johnson, Julia V
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621397/
https://www.ncbi.nlm.nih.gov/pubmed/19209272
_version_ 1782163406787182592
author Wright, Kristen Page
Johnson, Julia V
author_facet Wright, Kristen Page
Johnson, Julia V
author_sort Wright, Kristen Page
collection PubMed
description Oral contraceptives are classically given in a cyclic manner with 21 days of active pills followed by 7 days of placebo. In the past 4 years, new oral contraceptives have been introduced which either shorten the placebo time, lengthen the active pills (extended cycle), or provide active pills every day (continuous). These concepts are not new; extended and continuous pills were first studied in the 1960s and 1970s and have been provided in an off-label manner by gynecologists to treat menstrual disorders, such as menorrhagia and dysmenorrhea, and gynecologic disorders, such as endometriosis. Now that extended and continuous combined oral contraceptives are available for all patients, it is critical for providers to understand the physiology, dosing, side effects, and benefits of this form of oral contraceptive. This article reviews the history and the potential uses of the new continuous combined oral contraceptive.
format Text
id pubmed-2621397
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26213972009-02-10 Evaluation of extended and continuous use oral contraceptives Wright, Kristen Page Johnson, Julia V Ther Clin Risk Manag Review Oral contraceptives are classically given in a cyclic manner with 21 days of active pills followed by 7 days of placebo. In the past 4 years, new oral contraceptives have been introduced which either shorten the placebo time, lengthen the active pills (extended cycle), or provide active pills every day (continuous). These concepts are not new; extended and continuous pills were first studied in the 1960s and 1970s and have been provided in an off-label manner by gynecologists to treat menstrual disorders, such as menorrhagia and dysmenorrhea, and gynecologic disorders, such as endometriosis. Now that extended and continuous combined oral contraceptives are available for all patients, it is critical for providers to understand the physiology, dosing, side effects, and benefits of this form of oral contraceptive. This article reviews the history and the potential uses of the new continuous combined oral contraceptive. Dove Medical Press 2008-10 2008-10 /pmc/articles/PMC2621397/ /pubmed/19209272 Text en © 2008 Dove Medical Press Limited. All rights reserved
spellingShingle Review
Wright, Kristen Page
Johnson, Julia V
Evaluation of extended and continuous use oral contraceptives
title Evaluation of extended and continuous use oral contraceptives
title_full Evaluation of extended and continuous use oral contraceptives
title_fullStr Evaluation of extended and continuous use oral contraceptives
title_full_unstemmed Evaluation of extended and continuous use oral contraceptives
title_short Evaluation of extended and continuous use oral contraceptives
title_sort evaluation of extended and continuous use oral contraceptives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621397/
https://www.ncbi.nlm.nih.gov/pubmed/19209272
work_keys_str_mv AT wrightkristenpage evaluationofextendedandcontinuoususeoralcontraceptives
AT johnsonjuliav evaluationofextendedandcontinuoususeoralcontraceptives